Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

OTHER 561INDUSTRY 175NIH 81NETWORK 47UNKNOWN 5OTHER_GOV 3FED 1

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 2Thoracic 1

Conditions

Glioblastoma 2Neoplasm Metastasis 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 50Capecitabine 42apatinib 34Radiotherapy 33Oxaliplatin 33Gemcitabine 33Cyclophosphamide 32Drug Therapy 31Paclitaxel 30Carboplatin 29tislelizumab 27Irinotecan 27Fluorouracil 26Docetaxel 26Bevacizumab 23Surgical Procedures, Operative 21Nivolumab 19pembrolizumab 18fludarabine 18Radiation 16Metformin 16Exercise 16camrelizumab 15S 1 (combination) 14Control Groups 14Blood Specimen Collection 14Pemetrexed 13Standard of Care 12anlotinib 11Neoadjuvant Therapy 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER_GOV × Temozolomide × Clear all
NCT06419946 2026-04-13

Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma

Vastra Gotaland Region

Phase 3 Recruiting
200 enrolled
CNS

Glioblastoma

NCT02029573 2017-08-18

ART

King Fahad Medical City

Phase 2 Completed
36 enrolled
CNS

Glioblastoma

NCT00268684 2006-02-28

Comparison Study of WBRT and SRS Alone Versus With Temozolomide or Erlotinib in Patients With Brain Metastases of NSCLC

Tel-Aviv Sourasky Medical Center

Phase 3 Unknown
381 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡